Intuitive Surgical, US46120E6023

Intuitive Surgical, Inc. stock (US46120E6023): shares hover around USD 425 ahead of next earnings update

02.06.2026 - 09:03:51 | ad-hoc-news.de

Intuitive Surgical, Inc. shares on Nasdaq remain near USD 425 at the start of June, with investors watching for the next quarterly update after solid first-quarter growth in procedures and systems placements.

Intuitive Surgical, US46120E6023
Intuitive Surgical, US46120E6023

Intuitive Surgical, Inc. shares on the Nasdaq Global Select Market were recently quoted around USD 424.59, little changed from the prior close on 05/29/2026, keeping the United States-based robotic surgery specialist in a consolidation phase after a strong multi-year run.

According to Nasdaq price data as relayed by MarketBeat, Intuitive Surgical stock closed at USD 424.59 on 05/29/2026, implying a market capitalization of roughly USD 150 billion at that time and reflecting a year-on-year decline of about 23% in the share price over the last 12 months.

In early trading at the beginning of the week of 06/01/2026, Business Insider data show the shares opening close to USD 420.93 on the Nasdaq platform, indicating only modest short-term volatility but underscoring that the stock is trading noticeably below recent highs from earlier in the year.

For retail investors in Germany, Intuitive Surgical is also accessible via German trading venues such as Tradegate, where the stock is quoted in euros based on the underlying Nasdaq listing, providing an additional access route beyond the United States home market.

The relatively stable price action at the start of June comes in the wake of Intuitive Surgical’s most recent quarterly report, which detailed continued growth in da Vinci surgical procedures and new system placements, and the market is now looking ahead to the next earnings announcement later in 2026 for fresh guidance on volume trends and margins.

As of: 06/02/2026

By the editorial team - specialized in equity coverage.

At a glance

  • Name: Intuitive Surgical
  • Sector/industry: Medical technology, robotic-assisted surgery
  • Headquarters/country: Sunnyvale, United States
  • Core markets: North America, Europe, Asia-Pacific hospitals and surgical centers
  • Key revenue drivers: da Vinci surgical system sales, instruments and accessories, and services linked to procedure volumes
  • Home exchange/listing venue: Nasdaq Global Select Market (ISRG)
  • Trading currency: USD

Intuitive Surgical, Inc.: core business model

Intuitive Surgical focuses on developing and commercializing robotic-assisted platforms like the da Vinci system and associated instruments, with revenue primarily generated from a mix of system sales, recurring instruments and accessories usage, and service contracts that scale with procedure volumes at hospitals worldwide.

Latest quarterly results for Intuitive Surgical, Inc. at a glance

In its most recent reported quarter, Intuitive Surgical highlighted ongoing growth in minimally invasive procedures performed with da Vinci systems, with double-digit percentage increases in procedure counts compared with the prior-year period, according to the company’s latest earnings release on its investor relations website.

The same quarterly update also described higher placements of da Vinci surgical systems across key regions, as well as expansion in recurring revenue from instruments, accessories, and services, which together have helped support overall top-line growth and reflect hospitals’ continued adoption of robotic-assisted surgery in the United States and internationally.

Read more

Additional news and developments on the stock can be explored via the linked overview pages.

More news on this stockInvestor relations

Sentiment and reactions on Intuitive Surgical, Inc.

Market participants are discussing Intuitive Surgical, Inc. around the current price consolidation and the outlook for robotic-surgery procedure growth on various social and video platforms.

YouTubeXTikTokInstagram

Conclusion

With Intuitive Surgical, Inc. trading around USD 425 on the Nasdaq in early June and showing a roughly 23% share-price pullback over the past 12 months, the market appears to be reassessing growth expectations after a long period of outperformance.

The latest quarterly report still pointed to robust increases in da Vinci procedure volumes and system placements, and investors will be watching the next earnings release to see whether these operational trends can translate into renewed share-price momentum in the United States and on secondary venues such as German trading platforms.

Disclaimer: This article does not constitute investment advice. The comprehensive scope of this informative article was made possible through the use of a.i.. Stocks are volatile financial instruments.

So schätzen die Börsenprofis Intuitive Surgical Aktien ein!

<b>So schätzen die Börsenprofis Intuitive Surgical Aktien ein!</b>
Seit 2005 liefert der Börsenbrief trading-notes verlässliche Anlage-Empfehlungen – dreimal pro Woche, direkt ins Postfach. 100% kostenlos. 100% Expertenwissen. Trage einfach deine E-Mail Adresse ein und verpasse ab heute keine Top-Chance mehr. Jetzt abonnieren.
Für. Immer. Kostenlos.
en | US46120E6023 | INTUITIVE SURGICAL | boerse | 69469234 | bgmi